In early July, I wrote to you about Chinook Therapeutics, Inc. (KDNY), a strong biotech stock that’s been on our Watchlist a few times. And I mentioned at the time that it had just become
As I write this on Friday morning, the Nasdaq is up roughly 2% for the week. The S&P 500 recorded four positive days in a row to start the week, and we are beginning to
Today, I want to revisit Chinook Therapeutics, Inc. (KDNY) and cover the latest move in the stock. Regular readers will know Chinook, as it was included on our Watchlist for the last two weeks… But
As I write this on Friday afternoon, the Nasdaq is down 5.6% for the week. As expected, the recent short-term bounce was a great opportunity to take a few short trades from better entry points.
Chinook Therapeutics, Inc. (Long Idea) I added Chinook Therapeutics, Inc. (KDNY) to the Watchlist last week, and it did not rise enough to hit our buy trigger. As I mentioned in the previous update, KDNY is
In Monday’s Watchlist Update, I explained that the new leaders of the current market environment seem to be biotechnology companies. Chemical, shipping and energy stocks had their run earlier this year, but as time went
It is vitally important to watch which stocks are making highs when the market is making lows. This is usually the next group of market leaders that can advance several hundred percent once the next
Chinook Therapeutics, Inc. (Long Idea) Chinook Therapeutics, Inc. (KDNY) is a biotech stock coming out of a two-year base pattern. Here’s how the chart is setting up… And here’s how the stock is setting up
Looking for an edge? Ross has the inside scoop on top analysis that will help grow your portfolio.. Receive a new stock opportunity every day and get ready to see your investment SURGE!
Join our daily newsletter and get notified daily on the next stock surge with Ross Givens
THIS MATERIAL IS OFFERED FOR EDUCATIONAL AND GENERAL INFORMATIONAL PURPOSES ONLY. NO INVESTMENT ADVICE OFFERED.
This is an advertisement for online information courses, workshops, classes and other educational programs relating to finance and investing. It is not an advertisement for investment advice. Pursuant to FTC regulations and federal law, Traders Agency, LLC intends for the information in this advertisement to be truthful and not misleading. Accordingly, any and all readers of this advertisement (this means you) are fully informed that none of the information, material, or courses that Traders Agency, LLC offers constitute investment advice as defined by the SEC and by federal law. These materials do not take into account a subscriber’s (this means your) particular investment objectives, financial situations or needs and is not intended as a recommendation, offer or solicitation (this means to you) for the purchase or sale of any security or investment strategy.
Under SEC regulations and federal law, the purchase, sale, or advice regarding any security, other financial instrument or system can only be performed by a registered/licensed industry representative such as, but not limited to, a registered investment advisor. It is very important todo your own analysis before making any investment based on your own personal circumstances.
Investing involves substantial risk and results are not guaranteed.
Neither Traders Agency, LLC nor its principals or affiliates are registered investment, legal, or tax advisors or broker/dealers.
Traders Agency, LLC is not registered with the SEC or licensed as an investment adviser. We do not offer investment or financial advice. Individual subscribers (this means you) are solely responsible for confirming the accuracy and appropriateness of the provided information for their own uses with their personal tax, finance, or legal advisor.
INVESTING INVOLVES RISK, INCLUDING THE POSSIBLE LOSS OF PRINCIPAL. PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS. RESULTS ARE NOT GUARANTEED.